—Symposium Reviews— |
|
Patients' Consent and Drug Safety of Investigational Products and Approved Drugs |
| ………Y. Hirayama and T. Suzuki-Nishimura |
…863 |
|
Pharmacists Contribute to the Safety of Medicines |
| ………S. Nishihara |
…865 |
|
Scientific Drug Safety Information for Patients' Consent |
| ………T. Suzuki-Nishimura |
…871 |
|
Demands and Expectations for Drug Companies |
| ………Y. Hirayama |
…877 |
|
Drug Safety—From Patients' Perspective |
| ………K. Kitazawa |
…881 |
|
Post-marketing Drug Safety Measures for the Attainment of Safer and More Effective Use of Drug |
| ………T. Kurokawa |
…885 |
|
Challenging the Development of New Anti-diabetic Medicine-Approaching from Educational, Clinical, and Research Fields- |
| ………Y. Yoshikawa and Y. Adachi |
…891 |
|
Learn and Relation, Basic Knowledge of Diabetes-Approach from an Educational Front- |
| ………A. Murakami, Y. Matsuno, S. Suzuki, and K. Kogure |
…893 |
|
The Present Condition of Diabetes and Its Treatment-From the Perspective of a Hospital Pharmacist- |
| ………N. Harada |
…901 |
|
Search for Antidiabetic Constituents of Medicinal Food |
| ………S. Nakamura, H. Matsuda, and M. Yoshikawa |
…909 |
|
Challenge of Creating Single-agents for the Treatment of Type 1 and 2 Diabetes by Targeting Retinoid X Receptor |
| ………H. Kakuta |
…917 |
|
Challenge of Studies on the Development of New Zn Complexes to Treat Diabetes Mellitus |
| ………Y. Yoshikawa, H. Sakurai, and H. Yasui |
…925 |
|
Education of Graduate School of Pharmaceutical Sciences in New Generation: Introduction |
| ………N. Hirasawa and N. Oku |
…931 |
|
Education for Six-years Graduate School of Pharmaceutical Sciences: A Case of Tohoku University |
| ………Y. Tomioka, N. Hirasawa, and A. Naganuma |
…933 |
|
Expectations for the Education of Graduate School of Pharmaceutical Sciences from the Viewpoint of Discovery and Development of New Drugs |
| ………K. Ohmori |
…939 |
|
Education in Graduate School of Pharmaceutical Sciences |
| ………H. Yoshida |
…945 |
—Review— |
|
Distribution and Accumulation of Antibiotics in Cells and Tissues and Toxicity Studies by Immunocytochemistry |
| ………K. Fujiwara |
…949 |
—Regular Articles— |
|
Sasa quelpaertensis Phenylpropanoid Derivative Suppresses Lipopolysaccharide-induced Nitric Oxide Synthase and Cyclo-oxygenase-2 Expressions in RAW 264.7 Cells |
| ………J.-Y. Moon, E.-J. Yang, S. S. Kim, J.-Y. Kang, G.-O. Kim, N. H. Lee, and C.-G. Hyun |
…961 |
|
Current Status and Future Directions for Clinical Trials Pharmacy |
| ………H.-Oh La, S. Choi, S.-K. Lee, B.-E. Ryu, and O.-Y. Han |
…969 |
|
Identification of Dimethoate-containing Water Using Partitioned Dispersive Liquid-liquid Microextraction Coupled with Near-infrared Spectroscopy |
| ………M. Zhang, Y. Geng, and B. Xiang |
…977 |
|
An In Vitro Evaluation for Corneal Damages by Anti-glaucoma Combination Eye Drops Using Human Corneal Epithelial Cell (HCE-T) |
| ………N. Nagai, T. Murao, K. Oe, Y. Ito, N. Okamoto, and Y. Shimomura |
…985 |
—Article— |
|
Induction of Differentiation by Panaxydol in Human Hepatocarcinoma SMMC-7721 Cells via cAMP and MAP Kinase Dependent Mechanism |
| ………Z.-J. Wang, L. Song, L.-C. Guo, M. Yin, and Y. N. Sun |
…993 |